News

Array has reported top-line results from its phase-I seven-day dose escalation trial up to 1200mg daily of p38 inhibitor, ARRY-797, in healthy volunteers. The top-line results were announced

Cytheris has received Notice of Allowance from the US Patent and Trademark Office (USPTO), for its patent application IL-7 Drug Substance, Composition, Preparation and Uses, US Patent Application

Alnylam shall contribute more than 1500 issued or pending patents on its RNA interference (RNAi) technology patent estate, to the patent pool established by GlaxoSmithKline (GSK). Alnylam to

Watson Laboratories, a subsidiary of Watson’s, has received approval from the FDA to market its over-the-counter Nicotine Polacrilex Gum USP, 2mg and 4mg strengths, in the coated fruit

Salvat and WraSer Pharmaceuticals have entered into an exclusive license agreement to market Salvat’s Cetraxal in the US, for a period of ten years. The company said that

Repros has entered into the sixth amendment to its agreement with the National Institutes of Health (NHI), relating to Proellex. The company said that the amendment has revised

Transdel has completed the enrollment of patients in pivotal phase-III clinical study for Ketotransdel, a topical cream-based non-steroidal anti-inflammatory drug (NSAID) for acute pain. Moreover, the company expects

Marc Grossman has filed a civil lawsuit against the manufacturer of Zicam nasal spray, and the national drugstore chain that sold the product to a New York citizen.

Wyeth and Takeda have received approval from the Japanese Ministry of Health, Labour and Welfare, to add the indication of treating polyarticular Juvenile Idiopathic Arthritis (JIA) to Enbrel